Investors must take note of AMGEN Inc’s (AMGN) performance last week, which was -4.30%.

On Monday, AMGEN Inc (NASDAQ: AMGN) opened lower -1.30% from the last session, before settling in for the closing price of $277.29. Price fluctuations for AMGN have ranged from $253.30 to $346.85 over the past 52 weeks.

A company in the Healthcare sector has jumped its sales by 7.57% annually for the last half of the decade. Company’s average yearly earnings per share was noted 4.12% at the time writing. With a float of $536.43 million, this company’s outstanding shares have now reached $536.90 million.

In an organization with 28000 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 61.53%, operating margin of 21.71%, and the pretax margin is 13.79%.

AMGEN Inc (AMGN) Insider and Institutional Ownership

A key investor’s attitude towards the stock of the Drug Manufacturers – General industry is another important factor to consider. The insider ownership of AMGEN Inc is 0.23%, while institutional ownership is 79.14%. The most recent insider transaction that took place on Feb 19 ’25, was worth 2,550,903. In this transaction EVP, Operations of this company sold 8,711 shares at a rate of $292.84, taking the stock ownership to the 71,546 shares. Before that another transaction happened on Feb 21 ’25, when Company’s EVP & Chief Technology Officer sold 25,225 for $304.44, making the entire transaction worth $7,679,524. This insider now owns 36,922 shares in total.

AMGEN Inc (AMGN) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of 5.31 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 4.12% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.22% during the next five years compared to -10.10% drop over the previous five years of trading.

AMGEN Inc (NASDAQ: AMGN) Trading Performance Indicators

Check out the current performance indicators for AMGEN Inc (AMGN). In the past quarter, the stock posted a quick ratio of 0.95. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.43. Likewise, its price to free cash flow for the trailing twelve months is 14.16.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 7.55, a number that is poised to hit 4.28 in the next quarter and is forecasted to reach 21.53 in one year’s time.

Technical Analysis of AMGEN Inc (AMGN)

Let’s dig in a bit further. During the last 5-days, its volume was 2.78 million. That was inferior than the volume of 3.23 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 29.60%. Additionally, its Average True Range was 10.52.

During the past 100 days, AMGEN Inc’s (AMGN) raw stochastic average was set at 24.68%, which indicates a significant increase from 13.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 40.41% in the past 14 days, which was higher than the 27.50% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $303.42, while its 200-day Moving Average is $305.44. However, in the short run, AMGEN Inc’s stock first resistance to watch stands at $277.83. Second resistance stands at $281.99. The third major resistance level sits at $285.73. If the price goes on to break the first support level at $269.94, it is likely to go to the next support level at $266.20. The third support level lies at $262.05 if the price breaches the second support level.

AMGEN Inc (NASDAQ: AMGN) Key Stats

There are currently 537,651K shares outstanding in the company with a market cap of 147.14 billion. Presently, the company’s annual sales total 33,424 M according to its annual income of 4,090 M. Last quarter, the company’s sales amounted to 9,086 M and its income totaled 627,000 K.